Carr Financial Group’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $538K | Buy |
14,019
+164
| +1% | +$6.3K | 0.16% | 91 |
|
|
2025
Q1 | $537K | Sell |
13,855
-2,168
| -14% | -$84K | 0.18% | 86 |
|
|
2024
Q4 | $542K | Buy |
16,023
+75
| +0.5% | +$2.54K | 0.17% | 87 |
|
|
2024
Q3 | $652K | Buy |
15,948
+147
| +0.9% | +$6.01K | 0.19% | 88 |
|
|
2024
Q2 | $608K | Sell |
15,801
-213
| -1% | -$8.2K | 0.19% | 88 |
|
|
2024
Q1 | $687K | Buy |
16,014
+213
| +1% | +$9.13K | 0.23% | 73 |
|
|
2023
Q4 | $586K | Hold |
15,801
| – | – | 0.22% | 76 |
|
|
2023
Q3 | $544K | Buy |
15,801
+613
| +4% | +$21.1K | 0.22% | 82 |
|
|
2023
Q2 | $541K | Buy |
15,188
+504
| +3% | +$18K | 0.22% | 85 |
|
|
2023
Q1 | $527K | Hold |
14,684
| – | – | 0.23% | 80 |
|
|
2022
Q4 | $521K | Buy |
+14,684
| New | +$521K | 0.27% | 79 |
|